Cyclic peptide compound and antibacterial agent comprising same

Novel cyclic peptide compounds with modified side chains address the metabolic stability and efficacy limitations of existing ADEPs by achieving substantial enhancements in antibacterial activity against drug-resistant bacteria, demonstrating improved metabolic stability and broad-spectrum efficacy.

WO2024242056A1PCT designated stage expired Publication Date: 2024-11-28KINKI UNIVERSITY
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
PCT/JP2024/018354
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-22
Filing Date
2024-05-17
Publication Date
2024-11-28

AI Technical Summary

Technical Problem

Current cyclic peptide compounds, such as acyl depsipeptides (ADEPs), have limitations in metabolic stability and antibacterial activity, particularly against drug-resistant bacteria, with most studies focusing on optimizing the depsipeptide backbone rather than the side chain moiety, and commercially available ADEP1 shows limited in vivo antibacterial efficacy.

Method used

Development of novel cyclic peptide compounds with modified side chain structures, specifically through structural expansion of the side chain portion of a parent compound, resulting in derivatives with enhanced metabolic stability and significantly improved antibacterial activity against various bacterial strains, including drug-resistant bacteria.

Benefits of technology

The new cyclic peptide compounds demonstrate 32 to 128 times higher antibacterial activity compared to the positive control ADEP1 against certain strains, showcasing improved metabolic stability and broad-spectrum efficacy.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure JP2024018354_28112024_PF_FP_ABST
    Figure JP2024018354_28112024_PF_FP_ABST
Patent Text Reader

Abstract

It has been reported that acyldepsipeptides (ADEPs) disrupt intracellular protein degradation system complexes so as to exhibit strong antibacterial activities against various pathogenic bacteria including drug-resistant bacteria. In practice, however, it is hard to say that the antibacterial activities are sufficient. It has been confirmed that various cyclic peptide compounds represented by formula (1) according to the present invention exhibit extremely high antibacterial activities compared with ADEP1 and the like.
Need to check novelty before this filing date? Find Prior Art

Description

Cyclic peptide compound and antibacterial agent containing same

[0001] The present invention relates to cyclic peptide compounds having high antibacterial activity against bacteria.

[0002] In 2005, it was reported that acyldepsipeptides (ADEPs) isolated from Streptomyces hawaiiensis disrupt the intracellular protein degradation machinery complex and thereby exhibit potent antibacterial activity against various pathogenic bacteria, including drug-resistant bacteria (Non-Patent Documents 1 and 2). The mechanism of action is based on the following:

[0003] 1) Inhibition of ATPase-ClpP protein-protein interaction due to binding of ADEPs to ClpP. 2) Disruption of the ClpP regulatory mechanism. 3) Degradation of FtsZ, a protein involved in cell division, by the ADEPs-ClpP complex. 4) Cell death.

[0004] Due to the unique mechanism of action of ADEPs, structure-activity relationship (SAR) studies of ADEPs have been intensively conducted.

[0005] Brotz-Oesterhelt et al. , Nat. Med. 2005, 11, 1082; Conlon et al. , Nature 2013, 503, 365Griffith et al. ACS infection. Dis, 2019, 5, 1915 Yangxiong et al. ACS Med. Chem. Lett. 2017, 8, 1171-1176

[0006] However, most of these SAR studies have been limited to the optimization of the depsipeptide backbone, while the ADEP side chain contains an electrophilic reactive α,β-unsaturated carbonyl group found in many covalent drugs.

[0007] Although the α,β-unsaturated carbonyl group is one of the factors contributing to low metabolic stability, only one SAR study has been reported (Non-Patent Document 3). Furthermore, it is difficult to say that the only commercially available ADEP1 has a sharp antibacterial activity in vivo (Bacillus subtilis strain 168:IC). 50=0.2 mg / mL: Non-Patent Document 1).

[0008] The present invention was conceived in view of the above problems, and by conducting SAR studies on the side chain portion, highly active derivatives with improved metabolic stability were created, resulting in the production of new antibacterial agents.

[0009] More specifically, the cyclic peptide compound according to the present invention is a cyclic peptide compound having a structure of formula (1).

[0010]

[0011] Here, R1 is any one of a phenyl group, a naphthyl group, a cyclohexyl group, an adamantane group, a C3 to C18 linear alkyl group, and a phenyl group in which any hydrogen is substituted (the substituted functional group is at least one of a C3 to C18 linear alkyl group, a C1 to C3 alkoxyl group, a halogen group, a C1 to C3 perfluoroalkyl group, a nitro group, a trifluoromethoxy group, and a cyclopentyl group).

[0012] Antibacterial tests were carried out using the positive control ADEP1, compound 1, and the present compound group against B. subtilis ATCC6051, Staphylococcus epidermidis ATCC12228, and B. cereus ATCC11778, and the following results were obtained.

[0013] (1) Against B. subtilis ATCC6051, compounds (3), (4), (5), (6), (7), and (8) exhibited antibacterial activity 32-fold, 128-fold, 4-fold, 4-fold, 4-fold, and 16-fold higher than that of ADEP1.

[0014] Furthermore, compound (3), compound (4), and compound (9) exhibited antibacterial activity 6 times, 26 times, and 3 times higher than that of compound 1. On the other hand, compound (5), compound (6), and compound (7) exhibited antibacterial activity at the same level as compound 1.

[0015] (2) Compound (3) exhibited antibacterial activity against S. epidermidis ATCC 12228 that was 32 times higher than that of ADEP1. Furthermore, compound (3) exhibited antibacterial activity that was twice as high as that of compound 1.

[0016] (3) Against B. cereus ATCC11778, compounds (3), (5), (14), and (16) exhibited antibacterial activity twice as high as that of ADEP1.

[0017] 1 shows a reaction scheme for the cyclic peptide compound according to the present invention. 2 shows a known reaction scheme for the synthesis of the starting material for the cyclic peptide compound according to the present invention.

[0018] The novel cyclic peptide compound according to the present invention and an antibacterial agent containing the compound as an active ingredient will be described below with reference to examples. Note that the following description is an example of one embodiment and one example of the present invention, and the present invention is not limited to the following description. The following embodiment can be modified without departing from the spirit of the present invention.

[0019] The present invention relates to a cyclic peptide compound having the structure of the following formula (1):

[0020]

[0021] Here, R1 is any one of a phenyl group, a naphthyl group, a cyclohexyl group, an adamantane group, a C3 to C18 linear alkyl group, and a phenyl group in which any hydrogen is substituted (the substituted functional group is at least one of a C3 to C18 linear alkyl group, a C1 to C3 alkoxyl group, a halogen group, a C1 to C3 perfluoroalkyl group, a nitro group, a trifluoromethoxy group, and a cyclopentyl group). Note that C represents carbon, and the number after C indicates the number of carbon atoms.

[0022] The cyclic peptide compound of formula (1) was obtained as a new substance through SAR research using compound 1 shown in formula (2) as the parent compound.

[0023]

[0024] Compound 1 was chosen as the parent compound because it is easy to synthesize, is one of the synthetic compounds that exhibits high activity, and has a proven track record of being used as a positive control in many studies.

[0025] The cyclic peptide compound according to the present invention was synthesized by structurally expanding the side chain portion of compound 1 to synthesize compound 1 derivatives having different side chain structures.

[0026] The cyclic peptide compound according to the present invention can be synthesized by the reaction scheme shown in Figure 1. That is, it can be obtained by subjecting the synthesized compound (23) to a coupling reaction with an isocyanate having a functional group R1 bonded thereto. Compound (23) (see Figure 1) was synthesized by the method disclosed in Non-Patent Document 4. The reaction scheme is shown in Figure 2. Referring to Figure 2, when R is hydrogen in the substance (S6), it is compound (23).

[0027] That is, the cyclic peptide compound according to the present invention can be produced by a step of subjecting compound (23) to a coupling reaction with an isocyanate having a functional group R1.

[0028] The present invention can also provide an antibacterial agent containing at least one of the above compounds as an active ingredient. The antibacterial agent of the present invention can be administered by intravenous, subcutaneous, or intramuscular injection. Furthermore, the antibacterial agent of the present invention may be formulated into an external preparation such as a liquid, ointment, cream, gelling agent, patch, or aerosol, and administered parenterally. When formulated as an external preparation, water, lower alcohol, solubilizer, surfactant, emulsion stabilizer, gelling agent, adhesive, and other necessary base components can be blended. In addition, additives such as vasodilators, adrenal cortical hormones, keratolytic agents, moisturizers, disinfectants, antioxidants, refreshing agents, fragrances, and colorants may be appropriately blended.

[0029] The cyclic peptide compound according to the present invention and its antibacterial activity will be described below with reference to examples. An isocyanate having 23 functional groups shown in formula (3) was prepared and subjected to a coupling reaction with a compound of formula (23).

[0030]

[0031] The numbers in formula (3) indicate functional group numbers, where functional group 1 is a phenyl group, functional group 2 is a naphthyl group, functional group 3 is a tolyl group, functional group 4 is an ethylphenyl group, functional group 5 is a butylphenyl group, functional group 6 is a p-methoxyphenyl group, functional group 7 is an ethoxyphenyl group, functional group 8 is a fluorophenyl group, functional group 9 is a chlorophenyl group, functional group 10 is a trifluorophenyl group, functional group 11 is a nitrophenyl group, functional group 12 is an acetophenyl group, functional group 13 is a C3 linear alkyl group, functional group 14 is a C4 linear alkyl group, functional group 15 is a C6 linear alkyl group, functional group 16 is a C7 linear alkyl group, functional group 17 is a C12 linear alkyl group, functional group 18 is a C18 linear alkyl group, functional group 19 is a cyclohexyl group, functional group 20 is an adamantane group, functional group 21 is a trifluoromethoxy group, functional group 22 is an m-methoxyphenyl group, and functional group 24 is a cyclopentyl group.

[0032] The compounds in which each functional group in formula (3) is R1 in formula (1) are designated as compounds (1) to (22) and compound (24), respectively. That is, the compounds are distinguished by the number of the functional group. Note that EtOAc represents ethyl acetate, and EtOH represents ethanol. The synthesis procedures for each compound are shown below.

[0033] (Method for producing compound (1)) Compound (23) (66 mg, 0.090 mmol) was dissolved in a mixed solvent of tetrahydrofuran (1 mL) and N,N-dimethylformamide (1 mL), and then phenyl isocyanate (12 μL, 0.11 mmol) and triethylamine (45 μL, 0.32 mmol) were added. The reaction solution was stirred at room temperature for 16 hours and then concentrated under reduced pressure. The residue was purified by column chromatography (EtOAc:EtOH=15:1) to obtain compound (1) as yellow crystals (43 mg, 65% yield based on compound (23)).

[0034] Regarding compound (1), 1 H-NMR, 13 The results of C-NMR and mass spectrometry (High-resolution electrospray ionization mass spectrometry, HR-ESI-MS) measurements are shown below.

[0035] 1 H-NMR (CDCl 3 )(chemical shift): 8.51 (d, J = 9.5 Hz, 1H), 7.93 (s, 1H), 7.45 (dd, J = 8.6, 1.1 Hz, 2H), 7.27 (dd-like, J = ca. 8.6, 7.4 Hz, 2H), 6.99 (tt, J = 7.4, 1.1 Hz, 1H), 6.80 (br d, J = ca. 10.0 Hz, 1H), 6.78 (dd-like, J = 7.6, 2.1 Hz, 1H), 6.67 (tt, J = 9.0, 2.1 Hz, 1H), 5.85 (d, J = 7.6 Hz, 1H), 5.15 (dd-like, J = ca. 8.2, 2.9 Hz, 1H), 4.93 (dq, J = 9.5, 6.6 Hz, 1H), 4.85 (dd, J = 11.8, 1.8 Hz, 1H), 4.78 (q, J = 6.9 Hz, 1H), 4.55 (ddd, J = 10.0, 10.0, 1.8 Hz, 1H), 4.47 (d, J = 8.5 Hz, 1H), 4.45 (ddd, J = 9.0, 7.6, 4.8 Hz, 1H), 3.78 (ddd, J = 11.5, 7.9, 5.0 Hz, 1H), 3.63 (ddd-like, J = 12.0, 8.7, 8.7 Hz, 1H), 3.58 (dd, J = 1, 10.0 Hz, 1H), 3.54 (ddd, J = 11.5, 7.3, 7.3 Hz, 1H), 3.39 (ddd, J = 12.0, 9.7, 3.3 Hz, 1H), 3.00 (dd, J = 13.3, 4.8 Hz, 1H), 2.92 (dd, J = 13.3, 9.0 Hz, 1H), 2.82 (s, 3H), 2.40 - 2.34 (m, 1H), 2.19 - 2.12 (m, 2H), 2.04 - 1.94 (m, 3H), 1.94 - 1.85 (m, 2H), 1.53 (d, J = 6.9 Hz, 3H), 1.35 (d, J = 6.6 Hz, 3H).

[0036] 13 C-NMR (CDCl 3 It should be noted that there may be some inaccuracies in the original text, such as "1, 10.0 Hz" in "3.58 (dd, J = 1, 10.0 Hz)" which might be a typo. And the text "1H), 3.58 (dd, J = 1, 10.0 Hz, 1H)" seems a bit strange in its format. But the translation is done based on the provided rules.) (chemical shift): 172.3, 172.0, 171.8, 170.7, 170.1, 164.7, 163.0 (dd, J=247, 12.9Hz), 154.7, 139.9 (d, J = 9.1Hz), 139.6, 128.9, 122.2, 118.3, 112.5 ( dd, J = 20.1, 3.8 Hz), 102.5 (t, J = 25.3 Hz), 64.9, 59.5, 56.7, 56.3, 55.3, 5 1.1, 48.0, 47.2, 46.5, 39.8, 30.96, 30.91, 30.6, 23.1.21.2, 17.5, 15.6.

[0037] HRMS (ESI+): [M+Na] + calcd for C 36 H 43 F 2 N 7 NaO 8 , 762.3039; found, 762.3026. The results were as above, and it was confirmed that the compound was compound (1).

[0038] (Method for producing compound (2)) Compound (23) (94 mg, 0.13 mmol) was dissolved in a mixed solvent of tetrahydrofuran (1 mL) and N,N-dimethylformamide (1 mL), and then 1-naphthyl isocyanate (22 μL, 0.15 mmol) and triethylamine (64 μL, 0.46 mmol) were added. The reaction solution was stirred at room temperature for 16 hours and then concentrated under reduced pressure. The residue was purified by column chromatography (EtOAc:EtOH=15:1) to obtain compound (2) as a red oily substance (22 mg, 22% yield based on compound (23)).

[0039] Regarding compound (2), 1 H-NMR, 13 The results of C-NMR and mass spectrometry (High-resolution electron spray ionization mass spectrometry, HR-ESI-MS) measurements are shown below.

[0040] 1 H-NMR (CDCl 3 ​) (Chemical chart): 8.62 (d, J = 9.5 Hz, 1H), 8.29 (s, 1H), 8.19-8.16 (m, 1H), 8.13 (d, J = 7.5 Hz, 1H), 7.84-7.81 (m, 1H), 7.55 (d, J = 8.2 Hz, 1H), 7.48-7.42 (m, 3H), 6.80 (d, J = 7.7, 2.0 Hz, 2H), 6.66 (tt, J = 9.0, 2.0 Hz, 1H) , 6.21 (d, J=7.3Hz, 1H), 5.19 (dd-like, J=8.4, 3.0 Hz, 1H), 4.98 (dq, J = 9.5, 6.6 Hz, 1H), 4.86 (dd, J = 11 .9, 1.8Hz, 1H), 4.79 (q, J=7.0Hz, 1H), 4.60 (ddd, J= 10.0, 10.0, 1.8Hz, 1H), 4.61-4.56 (m, 1H), 4.50 (br d, J=8.4Hz, 1H), 3.78 (ddd, J=11.6, 7.9, 5.0H z, 1H), 3.65 (dd, J=11.8, 10.0Hz, 1H), 3.64-3. 60 (m, 2H), 3.55 (ddd, J=11.5, 7.4, 7.4Hz, 1H), 3.50 (ddd, J=12.0, 10.0, 2.5Hz, 1H), 3.08 (dd, J=13.3, 4.7Hz, 1H), 2.98 (dd, J=13.3, 8.8Hz, 1H), 2.84 (s, 3H), 2.41-2.34 (m, 1H), 2.19-2.1 2 (m, 2H), 2.04-1.88 (m, 4H), 1.87-1.80 (m, 1H) , 1.54 (d, J=7.0Hz, 3H), 1.40 (d, J=6.6Hz, 3H).

[0041] 13 C-NMR (CDCl 3 ) (Chemistry): 172.4, 171.9, 171.8, 170.8, 170.1, 165.0, 162.9 (dd, J=247, 12.4Hz), 155.3, 140.0 (t, J=9.0Hz), 134.3, 134.1 ,128.6,126.0,125.9,125.7,125.6,123 . 2, 120.9, 116.8, 112.6 (d, J=23.0Hz), 1 02.4 (t, J=24.9Hz), 64.8, 59.5, 56.8, 56 .3,55.4,51.2,48.1,47.4,46.6,39.6,3 1.0, 30.9, 30.6, 23.1, 21.2, 17.5, 15.6. ​

[0042] HRMS (ESI+): [M+Na] + calcd for C 40 H 45 F 2 N 7 NaO 8 , 812.3195; found, 812.3178. These results confirmed that the compound was compound (2).

[0043] (Method for producing compound (3)) Compound (23) (79 mg, 0.11 mmol) was dissolved in a mixed solvent of tetrahydrofuran (1 mL) and N,N-dimethylformamide (1 mL), and then p-tolyl isocyanate (16 μL, 0.13 mmol) and triethylamine (54 μL, 0.39 mmol) were added. The reaction solution was stirred at room temperature for 16 hours and then concentrated under reduced pressure. The residue was purified by column chromatography (EtOAc:EtOH=15:1) to obtain compound (3) as yellow crystals (14 mg, 17% yield based on compound (23)).

[0044] Regarding compound (3), 1 H-NMR, 13 The results of C-NMR and mass spectrometry (High-resolution electron spray ionization mass spectrometry, HR-ESI-MS) measurements are shown below.

[0045] 1 H-NMR (CDCl 3 ​(Chemical history): 8.53(d, J = 9.5 Hz, 1H), 7.85(s, 1H), 7.33(d, J = 8.3 Hz, 2H), 7.17(br d, J = c a. 10.0 Hz, 1H), 7.07(d, J = 8.3 Hz, 2H), 6.76(ddd, J = 7.8, 2.3 Hz, 2H), 6.64(tt, J = 8.9, 2.3 Hz, 1H), 5.79(d, J = 7.8 Hz, 1H), 5.16(dd-like, J = c a. 8.3, 3.0Hz, 1H), 4.92 (dq, J=9.5, 6.6Hz, 1H), 4.84 (dd, J=11.7, 1.8 Hz, 1H), 4.77 (q, J=6.9Hz, 1H), 4.55 (ddd, J=10.0, 10.0, 1.8Hz, 1H), 4.55-4.51 (m, 1H), 4.46 (d, J=8.2Hz, 1H), 3.78 (ddd, J=11.5, 7.8, 5. 0Hz, 1H), 3.62 (ddd, J=11.9, 8.7, 8.7Hz, 1H), 3.59-3.53 (m, 1H), 3.5 5 (dd, J=11.7, 10.0Hz, 1H), 3.39 (ddd, J=11.9, 9.6, 2.8Hz, 1H), 2.9 8 (dd, J=13.3, 4.6Hz, 1H), 2.92 (dd, J=13.3, 8.7Hz, 1H), 2.81 (s, 3H) , 2.40-2.33 (m, 1H), 2.28 (s, 3H), 2.19-2.11 (m, 2H), 2.03-1.94 (m, 3 H), 1.93-1.83 (m, 2H), 1.53 (d, J=6.9Hz, 3H), 1.33 (d, J=6.6Hz, 3H).

[0046] 13 C-NMR (CDCl 3 ) (Chemistry): 172.3, 172.0, 171.9, 170.7, 170.1, 164.7, 162.9, (dd, J=247,1 2.4Hz), 154.8, 140.0 (t, J = 9.0Hz), 137.0, 131.6, 129.4, 118.4, 112.6 (dd , J=20.1, 3.9Hz), 102.3 (t, J=25.0Hz), 64.9, 59.5, 56.7, 56.3, 55.0, 51.1 , 48.0, 47.1, 46.6, 39.8, 30.91, 30.89, 30.6, 23.1, 21.2, 20.7, 17.4, 15.6.

[0047] ​HRMS (ESI+): [M+Na] + calcd for C 37 H 45 F 2 N 7 NaO 8 , 776.3195; found, 776.3192. These results confirmed that the compound was compound (3).

[0048] (Method for producing compound (4)) Compound (23) (76 mg, 0.10 mmol) was dissolved in a mixed solvent of tetrahydrofuran (1 mL) and N,N-dimethylformamide (1 mL), and then 4-ethylphenyl isocyanate (14 μL, 0.12 mmol) and triethylamine (52 μL, 0.37 mmol) were added. The reaction solution was stirred at room temperature for 16 hours and then concentrated under reduced pressure. The residue was purified by column chromatography (EtOAc:EtOH=15:1) to obtain compound (4) as white crystals (38 mg, 47% yield based on compound (23)).

[0049] Regarding compound (4), 1 H-NMR, 13 The results of C-NMR and mass spectrometry (High-resolution electron spray ionization mass spectrometry, HR-ESI-MS) measurements are shown below.

[0050] 1 H-NMR (CDCl 3 ​)(Chemical Shift): 8.52 (d, J = 9.5 Hz, 1H), 7.82 (s, 1H), 7.35 (d, J = 8.5 Hz, 2H), 7.10 (d, J = 8.5 Hz, 2H), 6.84 (br d, J = ca. 10.0 Hz, 1H), 6.77 (dd, J = 7.4, 2.3 Hz, 2H), 6.66 (tt, J = 9.0, 2.3 Hz, 1H), 5.81 (d, J = 7.7 Hz, 1H), 5.15 (dd - like, J = ca. 8.3, 3.0 Hz, 1H), 4.92 (dq, J = 9.5, 6.6 Hz, 1H), 4.85 (dd, J = 12.0, 1.8 Hz, 1H), 4.78 (q, J = 7.0 Hz, 1H), 4.55 (ddd, J = 10.0, 10.0, 1.8 Hz, 1H), 4.47 (br d, J = 8.4 Hz, 1H), 4.49 - 4.44 (m, 1H), 3.78 (ddd, J = 11.5, 7.9, 5.0 Hz, 1H), 3.63 (ddd, J = 12.0, 8.6, 8.6 Hz, 1H), 3.58 (dd, J = 12.0, 10.0 Hz, 1H), 3.57 - 3.52 (m, 1H), 3.39 (ddd, J = 12.0, 9.5, 3.2 Hz, 1H), 2.99 (dd, J = 13.3, 4.7 Hz, 1H), 2.92 (dd, J = 13.3, 8.8 Hz, 1H), 2.82 (s, 3H), 2.59 (q, J = 7.6 Hz, 2H), 2.41 - 2.33 (m, 1H), 2.19 - 2.12 (m, 2H), 2.04 - 1.94 (m, 3H), 1.93 - 1.85 (m, 2H), 1.53 (d, J = 7.0 Hz, 3H), 1.34 (d, J = 6.6 Hz, 3H), 1.20 (t, J = 7.6 Hz, 3H).

[0051] 13 C - NMR(CDCl 3 )(Chemical Shift): 172.3, 172.0, 171.8, 170.7, 170.1, 164.6, 163.5 (dd, J = 247, 12.6 Hz), 154.8, 140.0 (t, J = 9.1 Hz), 138.2, 137.1, 128.2, 118.5, 112.6 (d, J = 20.1 Hz), 102.4 (t, J = 25.2 Hz), 64.9, 59.5, 56.7, 56.3, 55.3, 51.1, 48.0, 47.2, 46.5, 39.8, 30.94, 30.90, 30.6, 28.2, 23.1, 21.2, 17.5, 15.7, 15.6.

[0052] HRMS (ESI+): [M+Na] + calcd for C 38 H 47 F 2 N 7 NaO 8 , 790.3352; found, 790.3333. These results confirmed that the compound was compound (4).

[0053] (Method for producing compound (5)) Compound (23) (66 mg, 0.090 mmol) was dissolved in a mixed solvent of tetrahydrofuran (1 mL) and N,N-dimethylformamide (1 mL), and then 4-butylphenyl isocyanate (19 μL, 0.11 mmol) and triethylamine (45 μL, 0.32 mmol) were added. The reaction solution was stirred at room temperature for 16 hours and then concentrated under reduced pressure. The residue was purified by column chromatography (EtOAc:EtOH=15:1) to obtain compound (5) as white crystals (28 mg, 40% yield based on compound (23)).

[0054] Regarding compound (5), 1 H-NMR, 13 The results of C-NMR and mass spectrometry (High-resolution electron spray ionization mass spectrometry, HR-ESI-MS) measurements are shown below.

[0055] 1 H-NMR (CDCl 3 ​)(Chemical Shift): 8.52 (d, J = 9.5 Hz, 1H), 7.84 (s, 1H), 7.36 (br d, J = ca. 10.0 Hz, 1H), 7.32 (d, J = 8.4 Hz, 2H), 7.08 (d, J = 8.4 Hz, 2H), 6.78 (dd, J = 7.5, 2.2 Hz, 2H), 6.66 (tt, J = 8.9, 2.2 Hz, 1H), 5.84 (d, J = 8.0 Hz, 1H), 5.17 (dd - like, J = 8.3, 3.0 Hz, 1H), 4.92 (dq, J = 9.5, 6.6 Hz, 1H), 4.83 (dd, J = 11.8, 1.8 Hz, 1H), 4.77 (q, J = 6.9 Hz, 1H), 4.54 (ddd, J = 10.0, 10.0, 1.8 Hz, 1H), 4.57 - 4.51 (m, 1H), 4.47 (br d, J = 8.4 Hz, 1H), 3.78 (ddd, J = 11.6, 7.8, 5.0 Hz, 1H), 3.66 (dd, J = 11.8, 10.0 Hz, 1H), 3.61 (ddd - like, J = ca. 12.0, 8.7, 8.7 Hz, 1H), 3.56 (ddd, J = 11.5, 7.3, 7.3 Hz, 1H), 3.39 (ddd, J = 12.0, 10.0, 2.7 Hz, 1H), 2.97 (dd, J = 13.4, 5.7, Hz, 1H), 2.95 (dd, J = 13.4, 8.0 Hz, 1H), 2.82 (s, 3H), 2.54 (t, J = 7.3 Hz, 2H), 2.41 - 2.34 (m, 1H), 2.19 - 2.11 (m, 2H), 2.03 - 1.94 (m, 3H), 1.94 - 1.84 (m, 2H), 1.58 - 1.54 (m, 2H), 1.53 (d, J = 6.9 Hz, 3H), 1.38 - 1.30 (m, 2H), 1.34 (d, J = 6.6 Hz, 3H), 0.91 (t, J = 7.4 Hz, 3H).

[0056] 13 C - NMR (CDCl 3) (chemical shift): 172.4, 171.94, 171.90, 170.6, 170.2, 165.1, 162.9 (dd, J=247, 12.4Hz), 155.0, 140.1 (t, J = 9.1Hz), 137.0, 136.9, 128.8, 118.6, 112.6 (br d, J=ca. 20.6Hz), 102.3 (t, J=25.3Hz), 64.8, 59.5, 56.8, 56.3, 54.8, 51.2, 48.0, 47.2, 46.6, 39.4, 34.9, 33.7, 30.91, 30.88, 30.6, 23.1, 22.3, 21.2, 17.4, 15.6, 13.9.

[0057] HRMS (ESI+): [M+Na] + calcd for C 40 H 51 F 2 N 7 NaO 8 , 818.3665; found, 818.3643. These results confirmed that the compound was compound (5).

[0058] (Method for producing compound (6)) Compound (23) (76 mg, 0.10 mmol) was dissolved in a mixed solvent of tetrahydrofuran (1 mL) and N,N-dimethylformamide (1 mL), and then 4-methoxyphenyl isocyanate (16 μL, 0.12 mmol) and triethylamine (52 μL, 0.37 mmol) were added. The reaction solution was stirred at room temperature for 16 hours and then concentrated under reduced pressure. The residue was purified by column chromatography (EtOAc:EtOH=15:1) to obtain compound (6) as white crystals (26 mg, yield based on compound (23) 34%).

[0059] Regarding compound (6), 1 H-NMR, 13 The results of C-NMR and mass spectrometry (High-resolution electron spray ionization mass spectrometry, HR-ESI-MS) measurements are shown below.

[0060] 1 H-NMR (CDCl 3 ​1H), 7.77 (d, J = 9.0 Hz, 2H), 7.10 (br d, J = ca. 10.0 Hz, 1H), 6.83 (d, J = 9.0 Hz, 2H), 6.79 (dd, J = 7 6 , 2.2 Hz, 2H), 6.84 (tt, J = 9.0 , 2.2 Hz, 1H), 5.83 (d, J = 7 9 Hz, 1H), 5.13 (d, J = 7 9 Hz, 1H), 5.29 (dd-like, J = 8.3 , 3.0 Hz, 1H), 6.93 (dq, J = 9.5 , 6 . 6Hz, 1H), 4.84 (dd, J=11.8, 1.8Hz, 1H), 4. 78 (q, J=6.9Hz, 1H), 4.55 (ddd, J=10.0, 10 .0, 1.8Hz, 1H), 4.47 (d, J=8.4Hz, 1H), 4.4 9-4.45 (m, 1H), 3.80-3.76 (m, 1H), 3.78 (s, 3H), 3.63 (dd, J=11.8, 10.0Hz, 1H), 3.61 ( ddd, J=12.0, 8.5, 8.5Hz, 1H), 3.54 (ddd, J =11.4, 7.4, 7.4Hz, 1H), 3.40 (ddd, J = 12.0 , 9.9, 3.1Hz, 1H), 2.98 (dd, J=13.4, 5.2Hz, 1H), 2.93 (dd, J=13.4, 8.7Hz, 1H), 2.81 (s , 3H), 2.40-2.34 (m, 1H), 2.19-2.12 (m, 2H) , 2.04-1.94 (m, 3H), 1.94-1.87 (m, 2H), 1. 53 (d, J=6.9Hz, 3H), 1.34 (d, J=6.6Hz, 3H).

[0061] 13 C-NMR (CDCl 3 ) (Chemistry): 172.4, 172.0, 171.9, 170.6, 170.1, 164.9, 162.9 (dd, J=248,12 .6Hz), 155.2, 155.1, 140.1 (t, J = 8.9Hz), 132.5, 120.4, 114.2, 112.6 (dd, J=20.7, 3.8Hz), 102.4 (t, J=25.1Hz) ,64.8,59.5,56.7,56.3,55.5,55.1, 51.2, 48.0, 47.2, 46.6, 39.6, 30.94, 30.89, 30.6, 23.1, 21.2, 17.4, 15.6.

[0062] HRMS (ESI+): [M+Na]​+ calcd for C 37 H 45 F 2 N 7 NaO 9 , 792.3145; found, 792.3081. These results confirmed that the compound was compound (6).

[0063] (Method for producing compound (7)) Compound (23) (76 mg, 0.10 mmol) was dissolved in a mixed solvent of tetrahydrofuran (1 mL) and N,N-dimethylformamide (1 mL), and then 4-ethoxyphenyl isocyanate (19 μL, 0.13 mmol) and triethylamine (56 μL, 0.40 mmol) were added. The reaction solution was stirred at room temperature for 16 hours and then concentrated under reduced pressure. The residue was purified by column chromatography (EtOAc:EtOH=15:1) to obtain compound (7) as yellow crystals (14 mg, 16% yield based on compound (23)).

[0064] Regarding compound (7), 1 H-NMR, 13 The results of C-NMR and mass spectrometry (High-resolution electron spray ionization mass spectrometry, HR-ESI-MS) measurements are shown below.

[0065] 1 H-NMR (CDCl 3 ​(Chemical Shift): 8.54 (d, J = 9.5 Hz, 1H), 7.73 (s, 1H), 7.33 (d, J = 9.2 Hz, 2H), 7.14 (br d, J = ca. 10.0 Hz, 1H), 6.82 (d, J = 9.2 Hz, 2H), 6.76 (dd, J = 7.8, 2.0 Hz, 2H), 6.65 (tt, J = 8.7, 2.0 Hz, 1H), 5.76 (d, J = 7.6 Hz, 1H), 5.16 (dd - like, J = 8.4, 3.0 Hz, 1H), 4.92 (dq, J = 9.5, 6.6 Hz, 1H), 4.84 (dd, J = 11.7, 1.6 Hz, 1H), 4.78 (q, J = 6.9 Hz, 1H), 4.55 (ddd, J = 10.0, 10.0, 1.6 Hz, 1H), 4.52 (ddd - like, J = ca. 8.7, 7.6, 4.8 Hz, 1H), 4.46 (br d, J = 8.2 Hz, 1H), 3.99 (q, J = 6.9 Hz, 2H), 3.77 (ddd, J = 11.5, 7.8, 5.0 Hz, 1H), 3.63 (ddd - like, J = ca. 11.9, 8.7, 8.7 Hz, 1H), 3.57 (dd, J = 11.7, 10.0 Hz, 1H), 3.58 - 3.52 (m, 1H), 3.41 (ddd, J = 11.9, 9.6, 3.0 Hz, 1H), 2.97 (dd, J = 13.3, 4.8 Hz, 1H), 2.92 (dd, J = 13.3, 8.7 Hz, 1H), 2.81 (s, 3H), 2.40 - 2.33 (m, 1H), 2.18 - 2.12 (m, 2H), 2.04 - 1.94 (m, 3H), 1.94 - 1.86 (m, 2H), 1.53 (d, J = 6.9 Hz, 3H), 1.39 (t, J = 6.9 Hz, 3H), 1.32 (d, J = 6.6 Hz, 3H).

[0066] 13 C - NMR (CDCl 3) (chemical shift): 172.3, 172.0, 171.9, 170.6, 170.1, 164.7, 162.9 (dd, J=247, 12. 5Hz), 155.0, 154.5, 140.0 (t, J = 9.1Hz), 132.6, 120.2, 114.9, 112.6 (dd, J = 20.1, 3.8Hz), 102.3 (t, J=25.4Hz), 64.9, 63.7, 59.5, 56.7, 56.3, 55.1, 51. 1, 48.0, 47.2, 46.5, 39.8, 30.92, 30.89, 30.6, 23.1, 21.2, 17.4, 15.6, 14.9.

[0067] HRMS (ESI+): [M+Na] + calcd for C 38 H 47 F 2 N 7 NaO 9 , 806.3301; found, 806.3286. The results were as above, and it was confirmed that the compound was compound (7).

[0068] (Method for producing compound (8)) Compound (23) (87 mg, 0.12 mmol) was dissolved in a mixed solvent of tetrahydrofuran (1 mL) and N,N-dimethylformamide (1 mL), and then 4-fluorophenyl isocyanate (16 μL, 0.14 mmol) and triethylamine (60 μL, 0.43 mmol) were added. The reaction solution was stirred at room temperature for 16 hours and then concentrated under reduced pressure. The residue was purified by column chromatography (EtOAc:EtOH=15:1) to obtain compound (8) as white crystals (18 mg, 20% yield based on compound (23)).

[0069] Regarding compound (8), 1 H-NMR, 13 The results of C-NMR and mass spectrometry (High-resolution electron spray ionization mass spectrometry, HR-ESI-MS) measurements are shown below.

[0070] 1 H-NMR (CDCl 3 ​(Chemical Shift): 8.53 (d, J = 9.5 Hz, 1H), 7.97 (s, 1H), 7.46 (br d, J = ca. 10.0 Hz, 1H), 7.39 (dd, J = 8.9, 4.8 Hz, 2H), 6.97 (dd, J = 8.9, 8.9 Hz, 2H), 6.75 (dd, J = 7.6, 2.2 Hz, 2H), 6.63 (tt, J = 8.9, 2.2 Hz, 1H), 5.80 (d, J = 7.8 Hz, 1H), 5.17 (dd - like, J = 8.3, 3.0 Hz, 1H), 4.93 (dq, J = 9.5, 6.6 Hz, 1H), 4.84 (dd, J = 11.7, 1.4 Hz, 1H), 4.78 (q, J = 6.9 Hz, 1H), 4.59 - 4.55 (m, 1H), 4.56 (ddd - like, J = ca. 10.0, 10.0, 1.4 Hz, 1H), 4.47 (br d, J = 8.5 Hz, 1H), 3.77 (ddd, J = 11.7, 7.8, 5.0 Hz, 1H), 3.61 (ddd - like, J = ca. 11.9, 8.7, 8.7 Hz, 1H), 3.57 (ddd, J = 11.7, 7.8, 7.8 Hz, 1H), 3.55 (dd, J = 11.7, 10.0 Hz, 1H), 3.39 (ddd, J = 11.9, 9.4, 2.5 Hz, 1H), 2.95 (dd, J = 13.3, 4.6 Hz, 1H), 2.92 (dd, J = 13.3, 8.7 Hz, 1H), 2.81 (s, 3H), 2.41 - 2.33 (m, 1H), 2.18 - 2.12 (m, 2H), 2.04 - 1.95 (m, 3H), 1.95 - 1.85 (m, 2H), 1.53 (d, J = 6.9 Hz, 3H), 1.33 (d, J = 6.6 Hz, 3H).

[0071] 13 C - NMR (CDCl 3) (chemical shift): 172.3, 171.94, 171.88, 170.8, 170.1, 164.9, 162.9 (dd, J = 247, 12.6 Hz) , 158.2 (d, J = 239 Hz), 154.9, 139.9 (t, J = 9.1 Hz), 135.5, 119.9 (d, J = 7.2 Hz), 115.4 ( d, J = 22.0Hz), 112.6 (dd, J = 20.1, 3.8Hz), 102.3 (t, J = 24.9Hz), 65.0, 59.5, 56.8, 56 .3, 54.9, 51.2, 48.0, 47.1, 46.6, 39.8, 30.93, 30.89, 30.6, 23.1, 21.2, 17.5, 15.6.

[0072] HRMS (ESI+): [M+Na] + calcd for C 38 H 42 F 3 N 7 NaO 8 , 780.2945; found, 780.2925. These results confirmed that the compound was compound (8).

[0073] (Method for producing compound (9)) Compound (23) (88 mg, 0.12 mmol) was dissolved in a mixed solvent of tetrahydrofuran (1 mL) and N,N-dimethylformamide (1 mL), and then 4-chlorophenyl isocyanate (22 mg, 0.14 mmol) and triethylamine (60 μL, 0.43 mmol) were added. The reaction solution was stirred at room temperature for 16 hours and then concentrated under reduced pressure. The residue was purified by column chromatography (EtOAc:EtOH=15:1) to obtain compound (9) as a colorless oil (47 mg, 50% yield based on compound (23)).

[0074] Regarding compound (9), 1 H-NMR, 13 The results of C-NMR and mass spectrometry (High-resolution electron spray ionization mass spectrometry, HR-ESI-MS) measurements are shown below.

[0075] 1 H-NMR (CDCl 3 ​)(Chemical shift): 8.49 (d, J = 9.5 Hz, 1H), 8.04 (s, 1H), 7.40 (d, J = 8.9 Hz, 2H), 7.23 (d, J = 8.9 Hz, 2H), 7.20 (br d, J = ca. 10.0 Hz, 1H), 6.77 (dd, J = 7.6, 2.2 Hz, 2H), 6.66 (tt, J = 9.0, 2.2 Hz, 1H), 5.85 (d, J = 7.8 Hz, 1H), 5.16 (dd - like, J = 8.4, 3.2 Hz, 1H), 4.93 (dq, J = 9.5, 6.6 Hz, 1H), 4.84 (dd, J = 11.8, 1.8 Hz, 1H), 4.77 (q, J = 6.9 Hz, 1H), 4.55 (ddd, J = 10.0, 10.0, 1.8 Hz, 1H), 4.51 (ddd - like, J = ca. 8.6, 7.8, 5.0 Hz, 1H), 4.47 (d, J = 8.4 Hz, 1H), 3.78 (ddd, J = 11.6, 7.8, 5.0 Hz, 1H), 3.60 (dd, J = 11.8, 10.0 Hz, 1H), 3.61 - 3.57 (m, 1H), 3.57 (ddd, J = 11.6, 6.9, 6.9 Hz, 1H), 3.36 (ddd, J = 12.0, 9.8, 3.0 Hz, 1H), 2.97 (dd, J = 13.4, 5.0 Hz, 1H), 2.93 (dd, J = 13.4, 8.6 Hz, 1H), 2.81 (s, 3H), 2.41 - 2.34 (m, 1H), 2.19 - 2.12 (m, 2H), 2.04 - 1.95 (m, 3H), 1.95 - 1.85 (m, 2H), 1.53 (d, J = 6.9 Hz, 3H), 1.33 (d, J = 6.6 Hz, 3H).

[0076] 13 C - NMR(CDCl 3 )(Chemical shift): 172.3, 171.9, 171.8, 170.8, 170.1, 164.9, 162.9 (dd, J = 247, 12.4 Hz), 154.9, 139.8 (t, J = 8.9 Hz), 138.2, 130.9, 128.9, 127.0, 119.4, 112.6 (dd, J = 20.6, 3.8 Hz), 102.4 (t, J = 25.1 Hz), 64.9, 59.5, 56.8, 56.3, 55.0, 51.2, 48.0, 47.1, 46.6, 39.7, 30.93, 30.89, 30.6, 23.1, 21.2, 17.4, 15.6.

[0077] HRMS (ESI+): [M+Na] + calcd for C 36 H 42 ClF 2 N 7 NaO 8 , 796.2649; found, 796.2625. These results confirmed that the compound was compound (9).

[0078] (Method for producing compound (10)) Compound (23) (75 mg, 0.10 mmol) was dissolved in a mixed solvent of tetrahydrofuran (1 mL) and N,N-dimethylformamide (1 mL), and then 4-(trifluoromethyl)phenyl isocyanate (18 μL, 0.12 mmol) and triethylamine (51 μL, 0.37 mmol) were added. The reaction solution was stirred at room temperature for 16 hours and then concentrated under reduced pressure. The residue was purified by column chromatography (EtOAc:EtOH=15:1) to obtain compound (10) as white crystals (14 mg, 18% yield based on compound (23)).

[0079] Regarding compound (10), 1 H-NMR, 13 The results of C-NMR and mass spectrometry (High-resolution electron spray ionization mass spectrometry, HR-ESI-MS) measurements are shown below.

[0080] 1 H-NMR (CDCl 3 ​)(Chemical history):8.50(d,J��=9.5Hz,1H)、8.10(s,1H)、7.47(d,J��=9.1Hz,2H)、7.14(br s,1H)、7.13(d,J��=9.1Hz,2H)、6.75(dd,J��=7.5,2.1Hz,2H)、6.65(tt,J��=8.9,2.1Hz,1H)、5.84(d,J��=7.6Hz,1H)、5.17(dd-like,J��=8.4,3.1Hz,1H ), 4.93 (dq, J=9.5, 6.6Hz, 1H), 4.84 (dd, J=11.8, 1.8Hz, 1H), 4.77 (q, J= 6.9Hz, 1H), 4.55 (ddd, J=10.0, 10.0 , 1.8Hz, 1H), 4.52 (ddd-like, J=ca. 8.7, 8.6, 4.7Hz, 1H), 4.47(br d, J=8.5Hz, 1H), 3.78 (ddd, J=11.4, 7.4, 5.0Hz, 1H), 3.61 (ddd, J=11.9, 8.6, 8.6Hz, 1H), 3.57 (d dd, J=11.4, 7.4, 7.4Hz, 1H), 3.55 (dd, J= 11.8, 1 0.0Hz, 1H), 3.37 (ddd, J=11.9, 9.7, 3.1Hz, 1H), 2 . 97 (dd, J=13.3, 4.7Hz, 1H), 2.92 (dd, J=13.3, 8. 7Hz, 1H), 2.81 (s, 3H), 2.41-2.35 (m, 1H), 2.20- 2.13 (m, 2H), 2.05-1.96 (m, 3H), 1.96-1.87 (m, 2 H), 1.53 (d, J=6.9Hz, 3H), 1.33 (d, J=6.6Hz, 3H).

[0081] 13 C-NMR (CDCl 3 ) (Chemistry): 172.2, 172.0, 171.8, 170.9, 170.1, 164.7, 162.9 (dd, J = 247, 12.4 Hz), 154.6, 143.8, 139.8 (t, J=8.9Hz) , 138.4, 121.8, 120.5 (q, J=255Hz), 119 . 1, 112.6 (dd, J=20.4, 3.8Hz), 102.4 (t , J=25.1Hz), 65.0, 59.5, 56.7, 56.3, 5 5.1, 51.2, 48.0, 47.2, 46.6, 39.8, 31.0, 30.9, 30.6, 23.2, 21.2, 17.5, 15.6.

[0082] ​HRMS (ESI+): [M+K] + calcd for C 37 H 42 F 5 KN 7 O 8 , 846.2652; found, 846.2852. These results confirmed that the compound was compound (10).

[0083] (Method for producing compound (11)) Compound (23) (60 mg, 0.082 mmol) was dissolved in a mixed solvent of tetrahydrofuran (1 mL) and N,N-dimethylformamide (1 mL), and then 4-nitrophenyl isocyanate (16 mg, 0.098 mmol) and triethylamine (41 μL, 0.30 mmol) were added. The reaction solution was stirred at room temperature for 16 hours and then concentrated under reduced pressure. The residue was purified by column chromatography (EtOAc:EtOH=15:1) to obtain compound (11) as yellow crystals (15 mg, 24% yield based on compound (23)).

[0084] Regarding compound (11), 1 H-NMR, 13 The results of C-NMR and mass spectrometry (High-resolution electron spray ionization mass spectrometry, HR-ESI-MS) measurements are shown below.

[0085] 1 H-NMR (CDCl 3 ​(Chemical history):8.64(s,1H),8.46(d,JJ=9.5Hz,1H),8.16(d,JJ=9.2Hz,2H),7.60(d,JJ=9.2Hz,2H),7.11(br d,JJ=ca. 10.0Hz,1H),6.76(dd,JJ=7.3,2.2Hz,2H),6.68(tt,JJ=8.9,2.2Hz,1H),5.99(d,JJ=7.6Hz,1H),5.16(dd-like,JJ=8.5,3.1Hz,1H),4.95( dq, J=9.5, 6.6Hz, 1H), 4.87 (dd, J=11.9, 1.7Hz, 1H), 4.77 (q, J=6.9 Hz, 1H), 4.56 (ddd, J=10.0, 10.0, 1.7Hz, 1H), 4.52 (ddd-like, J=ca. 8.8, 7.6, 4.7Hz, 1H), 4.49 (d, J=8.5Hz, 1H), 3.80 (ddd, J=11.6, 7.8, 5.0Hz, 1H), 3.62-3.5 7 (m, 2H), 3.56 (dd, J=11.9, 10.0Hz, 1H), 3.36 (ddd, J=12.0, 9.6, 3.0Hz, 1H), 3.01 (dd, J=13 . 4, 4.7Hz, 1H), 2.94 (dd, J=13.4, 8.8Hz, 1H), 2.81 (s, 3H), 2.42-2.35 (m, 1H), 2.20-2.14 (m , 2H), 2.06-1.98 (m, 3H), 1.98-1.89 (m, 2H), 1.54 (d, J=6.9Hz, 3H), 1.34 (d, J=6.6Hz, 3H).

[0086] 13 C-NMR (CDCl 3 )(Chemical Science):172.1,171.9,171.6,171.1,170.1,164.6,163.0(dd,J=247,12.4Hz),153.8,145.9,142.0,139.4(t,J=9.1Hz),125.3,117.2,112.6(br d, J=23.6Hz), 102.6 (t, J=25.1Hz), 65.1, 59.6, 56.8, 56.3, 55.1, 51 .2, 48.0, 47.2, 46.6, 39.7, 31.0, 30.9, 30.6, 23.2, 21.2, 17.4, 15.6.

[0087] HRMS(ESI+):[M+K] + calcd for C​36 H 42 F 2 N 8 NaO 10 , 807.2890; found, 807.2883. The results were as above, and it was confirmed that the compound was compound (11).

[0088] (Method for producing compound (12)) Compound (23) (79 mg, 0.11 mmol) was dissolved in a mixed solvent of tetrahydrofuran (1 mL) and N,N-dimethylformamide (1 mL), and then 4-acetylphenyl isocyanate (21 mg, 0.13 mmol) and triethylamine (54 μL, 0.39 mmol) were added. The reaction solution was stirred at room temperature for 16 hours and then concentrated under reduced pressure. The residue was purified by column chromatography (EtOAc:EtOH=15:1) to obtain compound (12) as a yellow oily substance (12 mg, 14% yield based on compound (23)).

[0089] Regarding compound (12), 1 H-NMR, 13 The results of C-NMR and mass spectrometry (High-resolution electron spray ionization mass spectrometry, HR-ESI-MS) measurements are shown below.

[0090] 1 H-NMR (CDCl 3 ​)(Chemical Shift): 8.49 (d, J = 9.5 Hz, 1H), 8.39 (s, 1H), 7.90 (d, J = 8.7 Hz, 2H), 7.53 (d, J = 8.7 Hz, 2H), 7.32 (br d, J = ca. 10.0 Hz, 1H), 6.76 (dd, J = 7.5, 2.3 Hz, 2H), 6.66 (tt, J = 9.0, 2.3 Hz, 1H), 5.96 (d, J = 7.5 Hz, 1H), 5.17 (dd-like, J = 8.3, 3.0 Hz, 1H), 4.95 (dq, J = 9.5, 6.6 Hz, 1H), 4.84 (dd, J = 11.7, 1.8 Hz, 1H), 4.77 (q, J = 6.9 Hz, 1H), 4.56 (ddd-like, J = 10.0, 10.0, 1.8 Hz, 1H), 4.53 (ddd-like, J = ca. 8.7, 7.5, 5.0 Hz, 1H), 4.48 (br d, J = 8.5 Hz, 1H), 3.78 (ddd, J = 11.5, 9.7, 3.0 Hz, 1H), 3.61 (ddd, J = 11.5, 8.5, 8.5 Hz, 1H), 3.58 (dd, J = 11.7, 10.0 Hz, 1H), 3.56 (ddd, J = 11.5, 6.9, 6.9 Hz, 1H), 3.36 (ddd, J = 11.5, 9.7, 3.0 Hz, 1H), 2.98 (dd, J = 13.5, 5.0 Hz, 1H), 2.93 (dd, J = 13.5, 8.7 Hz, 1H), 2.82 (s, 3H), 2.56 (s, 3H), 2.42 - 2.35 (m, 1H), 2.19 - 2.13 (m, 2H), 2.04 - 1.95 (m, 3H), 1.95 - 1.86 (m, 2H), 1.54 (d, J = 6.9 Hz, 3H), 1.33 (d, J = 6.6 Hz, 3H).

[0091] 13 C-NMR(CDCl 3 )(Chemical Shift): 197.0, 172.2, 171.9, 171.7, 170.9, 170.1, 164.9, 162.9 (dd, J = 247, 12.4 Hz), 154.3, 144.2, 139.7 (t, J = 8.6 Hz), 131.1, 129.9, 117.2, 112.6 (br d, J = 23.9 Hz), 102.5 (t, J = 25.1 Hz), 64.9, 59.6, 56.8, 56.3, 55.1, 51.2, 48.0, 47.1, 46.6, 39.7, 31.0, 30.9, 30.6, 26.3, 23.1, 21.2, 17.5, 15.6.

[0092] HRMS (ESI+): [M+K] + calcd for C 38 H 45 F 2 N 7 NaO 9 , 804.3145; found, 804.3140. The above results confirmed that the compound was compound (12).

[0093] (Method for producing compound (13)) Compound (23) (83 mg, 0.12 mmol) was dissolved in a mixed solvent of tetrahydrofuran (1 mL) and N,N-dimethylformamide (1 mL), and then propyl isocyanate (13 μL, 0.14 mmol) and triethylamine (58 μL, 0.42 mmol) were added. The reaction solution was stirred at room temperature for 16 hours and then concentrated under reduced pressure. The residue was purified by column chromatography (EtOAc:EtOH=15:2) to obtain compound (13) as a brown oily substance (12 mg, 15% yield based on compound (23)).

[0094] Regarding compound (13), 1 H-NMR, 13 The results of C-NMR and mass spectrometry (High-resolution electron spray ionization mass spectrometry, HR-ESI-MS) measurements are shown below.

[0095] 1 H-NMR (CDCl 3 ​)(Chemical Shift): 8.53 (d, J = 9.5 Hz, 1H), 6.74 (br d - like, J = ca. 5.8 Hz, 2H), 6.66 (br t - like, J = ca. 9.0 Hz, 1H), 6.63 - 6.68 (br, 1H), 5.55 (d, J = 7.7 Hz, 1H), 5.39 (br s - like, 1H), 5.15 (dd - like, J = ca. 8.0, 2.7 Hz, 1H), 4.88 (dq, J = 9.5, 6.6 Hz, 1H), 4.84 (br d - like, J = ca. 11.7 Hz, 1H), 4.77 (q, J = 6.9 Hz, 1H), 4.52 (br dd - like, J = ca. 10.0, 10.0, 1H), 4.45 (d, J = 8.5 Hz, 1H), 4.38 (ddd - like, J = ca. 8.8, 7.7, 5.0 Hz, 1H), 3.76 (ddd, J = 11.5, 8.0, 4.9 Hz, 1H), 3.62 - 3.55 (m, 2H), 3.52 (ddd, J = 11.4, 7.4, 7.4 Hz, 1H), 3.40 (ddd, J = 11.5, 9.0, 3.0 Hz, 1H), 3.21 - 3.15 (m, 2H), 2.92 (dd, J = 13.3, 5.0 Hz, 1H), 2.88 (dd, J = 13.3, 8.8 Hz, 1H), 2.81 (s, 3H), 2.39 - 2.32 (m, 1H), 2.20 - 2.11 (m, 2H), 2.06 - १.१ (m, 6H), 1.52 (d, J = 6.9 Hz, 3H), 1.54 - 1.47 (m, 2H), 1.31 (d, J = 6.6 Hz, 3H), 0.93 (t, J = 7.4 Hz, 3H).[[ID=१]] [[ID=२]]

[0096] [[ID=३]] [[ID=४]] 13 [[ID=५]]C - NMR(CDCl[[ID=६]] 3 It should be noted that there seems to be a typo in the original text where "१.१" appears instead of "1.91" in the chemical shift data. This has been left as is in the translation for the purpose of following the instructions precisely.) (chemical shift): 172.4, 172.0, 171.9, 170.3, 170.1, 164.7, 162.9 (dd, J = 246, 12.4 Hz), 157.6, 112.4 (dd, J = 20.3, 2.9 Hz), 102.3 (t, J=26.0Hz), 64.8, 59.4, 56.6, 56.3, 55.4, 51.0, 47.9, 47.0, 46.5, 41.9, 39.8, 30.9, 30.7, 23.6, 23.1, 21.2, 17.4, 15.6, 11.4. (The signal due to the ipso-carbonofthe3,5-difluorophenyl moiety wasnotobserve data around 140ppm.)

[0097] HRMS (ESI+): [M+Na] + calcd for C 33 H 45 F 2 N 7 NaO 8 , 728.3195; found, 728.3179. These results confirmed that the compound was compound (13).

[0098] (Method for producing compound (14)) Compound (23) (117 mg, 0.16 mmol) was dissolved in a mixed solvent of tetrahydrofuran (1 mL) and N,N-dimethylformamide (1 mL), and then butyl isocyanate (21 μL, 0.20 mmol) and triethylamine (82 μL, 0.59 mmol) were added. The reaction solution was stirred at room temperature for 3 hours and then concentrated under reduced pressure. The residue was purified by column chromatography (EtOAc:EtOH=15:1) to obtain compound (14) as a brown oily substance (13 mg, 11% yield based on compound (23)).

[0099] Regarding compound (14), 1 H-NMR, 13 The results of C-NMR and mass spectrometry (High-resolution electron spray ionization mass spectrometry, HR-ESI-MS) measurements are shown below.

[0100] 1 H-NMR (CDCl 3 ​)(Chemical Shift): 8.26 (d, J = 9.5 Hz, 1H), 8.05 (d, J = 7.3 Hz, 1H), 6.90 (br d, J = ca. 10.0 Hz, 1H), 6.77 (dd, J = 7.4, 2.3 Hz, 1H), 6.71 (tt, J = 9.0, 2.3 Hz, 1H), 5.15 (dd - like, J = ca. 8.5, 3.0 Hz, 1H), 4.87 (dq, J = 9.5, 6.6 Hz, 1H), 4.83 (dd, J = 11.8, 1.8 Hz, 1H), 4.77 (q, J = 6.9 Hz, 1H), 4.52 (ddd - like, J = ca. 8.9, 7.3, 5.1 Hz, 1H), 4.49 (d, J = 8.5 Hz, 1H), 4.48 (ddd - like, J = ca. 10.0, 10.0, 1.8 Hz, 1H), 3.78 (ddd, J = 11.6, 7.6, 4.8 Hz, 1H), 3.82 - 3.76 (m, 1H), 3.67 (ddd, J = 12.1, 8.0, 8.0 Hz, 1H), 3.58 (dd, J = 11.8, 10.0 Hz, 1H), 3.52 (ddd, J = 11.6, 7.3, 7.3 Hz, 1H), 3.31 (ddd, J = 12.1, 8.7, 5.0 Hz, 1H), 3.15 (t, J = 7.2 Hz, 2H), 3.05 (dd, J = 13.3, 5.1 Hz, 1H), 2.98 (dd, J = 13.3, 8.9 Hz, 1H), 2.84 (s, 3H), 2.40 - 2.34 (m, 1H), 2.25 - 2.18 (m, 1H), 2.18 - 2.11 (m, 1H), 2.04 - 1.91 (m, 5H), 1.54 (d, J = 6.9 Hz, 3H), 1.51 - 1.46 (m, 2H), 1.37 - 1.24 (m, 2H), 1.36 (d, J = 6.6 Hz, 3H), 0.93 (t, J = 7.4 Hz, 3H).

[0101] 13 C - NMR (CDCl 3) (chemical shift): 172.6, 171.9, 169.8, 169.5, 169.1, 164.7, 158.4, 163.0 (dd, J = 246, 12.4 Hz), 140.2 (t, J = 9.1 Hz), 158.4, 112.5 (dd, J = 21.2, 3.8 Hz), 1 03.0 (t, J=24.8Hz), 64.3, 59.0, 56.7, 56.2, 55.5, 51.5, 47.7, 46.8, 46. 6, 40.7, 38.2, 32.2, 30.9 (2C), 30.4, 23.1, 21.2, 20.0, 17.5, 15.5, 13.8.

[0102] HRMS (ESI+): [M+Na] + calcd for C 34 H 47 F 2 N 7 NaO 8 , 742.3352; found, 742.3339. These results confirmed that the compound was compound (14).

[0103] (Method for producing compound (15)) Compound (23) (109 mg, 0.15 mmol) was dissolved in a mixed solvent of tetrahydrofuran (1 mL) and N,N-dimethylformamide (1 mL), and then hexyl isocyanate (26 μL, 0.18 mmol) and triethylamine (76 μL, 0.55 mmol) were added. The reaction solution was stirred at room temperature for 16 hours and then concentrated under reduced pressure. The residue was purified by column chromatography (EtOAc:EtOH=20:1) to obtain compound (15) as brown crystals (12 mg, 11% yield based on compound (23)).

[0104] Regarding compound (15), 1 H-NMR, 13 The results of C-NMR and mass spectrometry (High-resolution electron spray ionization mass spectrometry, HR-ESI-MS) measurements are shown below.

[0105] 1 H-NMR (CDCl 3 ​)(Chemical Shift): 8.57 (d, J = 9.5 Hz, 1H), 7.17 (br d, J = ca. 10.0 Hz, 1H), 6.73 (br d, J = ca. 7.5 Hz, 2H), 6.64 (tt, J = 9.1, 2.0 Hz, 1H), 5.56 (d, J = 7.7 Hz, 1H), 5.43 (br s, 1H), 5.16 (dd - like, J = ca. 8.3, 3.0 Hz, 1H), 4.88 (dq, J = 9.5, 6.6 Hz, 1H), 4.83 (dd, J = 11.7, 1.5 Hz, 1H), 4.77 (q, J = 6.9 Hz, 1H), 4.52 (ddd, J = 10.0, 10.0, 1.5 Hz, 1H), 4.48 - 4.41 (m, 1H), 4.45 (d, J = 8.5 Hz, 1H), 3.79 - 3.73 (m, 1H), 3.62 - 3.57 (m, 1H), 3.60 (dd, J = 11.7, 10.0 Hz, 1H), 3.53 (ddd, J = 11.6, 7.4, 7.4 Hz, 1H), 3.40 (ddd, J = 11.5, 9.6, 2.8 Hz, 1H), 3.23 - 3.16 (m, 2H), 2.91 (br d - like, J = ca. 6.7, 2H), 2.80 (s, 3H), 2.39 - 2.32 (m, 1H), 2.21 - 2.11 (m, 2H), 2.06 - 2.01 (m, 1H), 2.01 - 1.91 (m, 4H), 1.52 (d, J = 6.9 Hz, 3H), 1.51 - 1.44 (m, 2H), 1.36 - 1.26 (m, 6H), 1.30 (d, J = 6.6 Hz, 3H), 0.88 (t, J = 6.1 Hz, 3H).

[0106] 13 C - NMR(CDCl 3 )(Chemical Shift): 172.5, 172.0 (2C), 170.3, 170.1, 164.9, 162.9 (dd, J = 246, 12.4 Hz), 157.6, 140.4 (t, J = 9.6 Hz), 112.5 (dd, J = 21.2, 3.8 Hz), 102.2 (t, J = 24.8 Hz), 64.9, 59.4, 56.6, 56.3, 55.1, 51.0, 47.9, 47.0, 46.5, 40.2, 39.7, 31.6, 30.9 (2C), 30.6, 30.4, 26.6, 23.1, 22.6, 21.2, 17.4, 15.6, 14.0.

[0107] HRMS(ESI +): [M + Na] +calcd for C 36 H 51 F 2 N 7 NaO 8 , 770.3659; found, 770.3660. These results confirmed that the compound was compound (15).

[0108] (Method for producing compound (16)) Compound (23) (135 mg, 0.19 mmol) was dissolved in a mixed solvent of tetrahydrofuran (1 mL) and N,N-dimethylformamide (1 mL), and then heptyl isocyanate (36 μL, 0.23 mmol) and triethylamine (45 μL, 0.68 mmol) were added. The reaction solution was stirred at room temperature for 16 hours and then concentrated under reduced pressure. The residue was purified by column chromatography (EtOAc:EtOH=15:1) to obtain compound (16) as white crystals (14 mg, 14% yield based on compound (23)).

[0109] Regarding compound (16), 1 H-NMR, 13 The results of C-NMR and mass spectrometry (High-resolution electron spray ionization mass spectrometry, HR-ESI-MS) measurements are shown below.

[0110] 1 H-NMR (CDCl 3 ​)(Chemical Shift): 8.57 (d, J = 9.5 Hz, 1H), 7.72 (br d, J = ca. 10.0 Hz, 1H), 6.74 (dd, J = 8.0, 2.1 Hz, 2H), 6.62 (tt, J = 8.9, 2.1 Hz, 1H), 5.58 (br d, J = 6.4 Hz, 1H), 5.54 (br s, 1H), 5.18 (dd - like, J = 8.3, 3.0 Hz, 1H), 4.88 (dq, J = 9.5, 6.6 Hz, 1H), 4.82 (dd, J = 11.7, 1.6 Hz, 1H), 4.77 (q, J = 6.9, Hz, 1H), 4.55 (ddd - like, J = ca. 7.1, 6.4, 5.2 Hz, 1H), 4.53 (ddd, J = 10.0, 10.0, 1.6 Hz, 1H), 4.45 (br d, J = ca. 8.5 Hz, 1H), 3.76 (ddd, J = 11.5, 8.0, 5.0 Hz, 1H), 3.64 (dd, J = 11.7, 10.0 Hz, 1H), 3.59 (ddd, J = 12.1, 8.7, 8.7 Hz, 1H), 3.57 (ddd - like, J = ca. 11.5, 6.9, 6.9 Hz, 1H), 3.40 (ddd, J = 12.1, 9.6, 2.7 Hz, 1H), 3.23 - 3.15 (m, 2H), 2.92 (dd, J = 12.6, 7.1 Hz, 1H), 2.88 (dd, J = 12.6, 5.2 Hz, 1H), 2.79 (s, 3H), 2.40 - 2.33 (m, 1H), 2.20 - 2.11 (m, 2H), 2.05 - 1.90 (m, 6H), 1.52 (d, J = 6.9 Hz, 3H), 1.51 - 1.46 (m, 2H), 1.34 - 1.22 (m, 8H), 1.29 (d, J = 6.6 Hz, 3H), 0.87 (t, J = 6.9 Hz, 3H).

[0111] 13 C - NMR (CDCl 3) (chemical shift): 172.5, 172.0, 171.92, 170.3, 170.1, 165.1, 162.7 (dd, J = 246, 12 .4Hz), 157.7, 140.5 (t, J=9.1Hz), 112.6 (dd, J=21.1, 3.8Hz), 102.0 (t, J=24 .. 9Hz), 64.9, 59.3, 56.7, 56.2, 54.6, 51.1, 47.9, 47.0, 46.6, 40.2, 39.4, 31. 7, 30.84, 30.81, 30.6, 30.3, 29.0, 26.8, 23.1, 22.5, 22.1, 17.3, 15.6, 14.0.

[0112] HRMS (ESI+): [M+Na] + calcd for C 37 H 53 F 2 N 7 NaO 8 , 784.3821; found, 784.3821. The results were as above, and it was confirmed that the compound was compound (16).

[0113] (Method for producing compound (17)) Compound (23) (98 mg, 0.14 mmol) was dissolved in a mixed solvent of tetrahydrofuran (1 mL) and N,N-dimethylformamide (1 mL), and then dodecyl isocyanate (40 μL, 0.16 mmol) and triethylamine (68 μL, 0.49 mmol) were added. The reaction solution was stirred at room temperature for 3 hours and then concentrated under reduced pressure. The residue was purified by column chromatography (EtOAc:EtOH=15:2) to obtain compound (17) as white crystals (16 mg, 15% yield based on compound (23)).

[0114] Regarding compound (17), 1 H-NMR, 13 The results of C-NMR and mass spectrometry (High-resolution electron spray ionization mass spectrometry, HR-ESI-MS) measurements are shown below.

[0115] 1 H-NMR (CDCl 3 ​(Chemical Shift): 8.56 (d, J = 9.5 Hz, 1H), 7.31 (br d, J = ca. 10.0 Hz, 1H), 6.74 (dd, J = 7.5, 2.3 Hz, 2H), 6.63 (tt, J = 9.0, 2.3 Hz, 1H), 5.57 (d, J = 7.9 Hz, 1H), 5.46 (br t - like, J = ca. 5.0 Hz, 1H), 5.16 (dd - like, J = ca. 8.3, 3.0 Hz, 1H), 4.89 (dq, J = 9.5, 6.6 Hz, 1H), 4.83 (dd, J = 11.7, 1.6 Hz, 1H), 4.77 (q, J = 6.9 Hz, 1H), 4.52 (ddd - like, J = ca. 10.0, 10.0, 1.6 Hz, 1H), 4.47 (dt - like, J = ca. 7.9, 6.8 Hz, 1H), 4.45 (d, J = 8.4 Hz, 1H), 3.76 (ddd, J = 11.6, 7.8, 5.0 Hz, 1H), 3.62 (dd, J = 11.7, 10.0 Hz, 1H), 3.59 (ddd, J = 11.8, 8.5, 8.5 Hz, 1H), 3.54 (ddd, J = 11.6, 7.3, 7.3 Hz, 1H), 3.40 (ddd, J = 11.8, 10.0, 2.9 Hz, 1H), 3.23 - 3.15 (m, 2H), 2.90 (d - like, J = ca. 6.8 Hz, 2H), 2.80 (s, 3H), 2.40 - 2.33 (m, 1H), 2.20 - 2.11 (m, 2H), 2.05 - 2.01 (m, 1H), 2.01 - 1.89 (m, 4H), 1.52 (d, J = 6.9 Hz, 3H), 1.51 - 1.45 (m, 2H), 1.34 - 1.24 (m, 18H), 1.30 (d, J = 6.6 Hz, 3H), 0.88 (t, J = 7.0 Hz, 3H).

[0116] 13 C - NMR (CDCl 3) (chemical shift): 172.5, 171.97, 171.95, 170.3, 170.1, 165.9, 162.8 (dd, J = 247.6, 12.4 Hz), 157.7, 140.4 (t, J = 9.1 Hz), 112.5 (dd, J = 20.1, 3.8 Hz), 102.2 (t, J = 24.9 Hz), 6 4.9, 59.4, 56.6, 56.2, 55.0, 51.1, 47.9, 47.0, 46.5, 40.2, 39.6, 31.9, 30.9, 30.6, 30.4, 29.66, 29.62, 29.60, 29.4, 29.3, 26.9, 23.1, 22.7, 21.2, 17.4, 15.6, 14.1.

[0117] HRMS (ESI+): [M+H] + calcd for C 42 H 64 F 2 N 7 O 8 , 832.4779; found, 832.4746. These results confirmed that the compound was compound (17).

[0118] (Method for producing compound (18)) Compound (23) (130 mg, 0.18 mmol) was dissolved in a mixed solvent of tetrahydrofuran (1 mL) and N,N-dimethylformamide (1 mL), and then octadecyl isocyanate (75 μL, 0.22 mmol) and triethylamine (91 μL, 0.65 mmol) were added. The reaction solution was stirred at room temperature for 16 hours and then concentrated under reduced pressure. The residue was purified by column chromatography (EtOAc:EtOH=15:2) to obtain compound (18) as white crystals (55 mg, yield based on compound (23) 33%).

[0119] Regarding compound (18), 1 H-NMR, 13 The results of C-NMR and mass spectrometry (High-resolution electron spray ionization mass spectrometry, HR-ESI-MS) measurements are shown below.

[0120] 1 H-NMR (CDCl 3 ​)(Chemical Shift): 8.56 (d, J = 9.5 Hz, 1H), 7.34 (br d, J = ca. 10.0 Hz, 1H), 6.74 (dd, J = 7.8, 2.3 Hz, 2H), 6.64 (tt, J = 8.9, 2.3 Hz, 1H), 5.53 (d, J = 7.8 Hz, 1H), 5.45 (br t-like, J = ca. 6.0, 1H), 5.16 (dd-like, J = ca. 8.5, 3.0 Hz, 1H), 4.88 (dq, J = 9.5, 6.6 Hz, 1H), 4.84 (dd, J = 11.6, 1.6 Hz, 1H), 4.77 (q, J = 6.9 Hz, 1H), 4.53 (ddd, J = 10.0, 10.0, 1.6 Hz, 1H), 4.52 (dt-like, J = 7.8, 6.7 Hz, 1H), 4.45 (d, J = 8.5 Hz, 1H), 3.76 (ddd, J = 11.9, 8.0, 5.0 Hz, 1H), 3.61 - 3.57 (m, 1H), 3.59 (dd, J = 11.6, 10.0 Hz, 1H), 3.57 (ddd, J = 11.9, 6.9, 6.9 Hz, 1H), 3.40 (ddd, J = 12.0, 9.9, 3.0 Hz, 1H), 3.23 - 3.16 (m, 2H), 2.91 (d-like, J = ca. 6.7 Hz, 2H), 2.79 (s, 3H), 2.39 - 2.33 (m, 1H), 2.20 - 2.11 (m, 2H), 2.05 - 2.01 (m, 1H), 2.01 - 1.88 (m, 4H), 1.52 (d, J = 6.8 Hz, 3H), 1.51 - 1.46 (m, 2H), 1.35 - 1.22 (m, 30H), 1.29 (d, J = 6.6 Hz, 3H), 0.88 (t, J = 7.0 Hz, 3H).<00°00522><00°00523> <00°00210>C-NMR(CDCl<00°00211>) (chemical shift): 172.5, 172.01, 171.97, 170.2, 170.0, 164.9, 162.8 (dd, J = 246, 12.4Hz) , 157.6, 140.5 (t, J = 9.1 Hz), 112.6 (dd, J = 20.1, 3.8 Hz), 102.1 (t, J = 24.8 Hz), 65.0, 59.4, 56.6, 56.2, 54.9, 51.0, 47.9, 47.0, 46.5, 40.2, 39.6, 31.9, 30.88, 30.84, 30.6, 30.5, 29.7, 29.62, 29.60, 29.4, 29.3, 27.0, 23.1, 22.7, 21.2, 17.4, 15.6, 14.1.

[0122] HRMS (ESI+): [M+Na] + calcd for C 48 H 75 F 2 N 7 NaO 8 , 938.5543; found, 938.5541. These results confirmed that the compound was compound (18).

[0123] (Method for producing compound (19)) Compound (23) (106 mg, 0.15 mmol) was dissolved in a mixed solvent of tetrahydrofuran (1 mL) and N,N-dimethylformamide (1 mL), and then cyclohexyl isocyanate (22 μL, 0.18 mmol) and triethylamine (74 μL, 0.53 mmol) were added. The reaction solution was stirred at room temperature for 3 hours and then concentrated under reduced pressure. The residue was purified by column chromatography (EtOAc:EtOH=15:1) to obtain compound (19) as white crystals (12 mg, 11% yield based on compound (23)).

[0124] Regarding compound (19), 1 H-NMR, 13 The results of C-NMR and mass spectrometry (High-resolution electron spray ionization mass spectrometry, HR-ESI-MS) measurements are shown below.

[0125] 1 H-NMR (CDCl 3 ​)(Chemical Shift): 8.54 (d, J = 9.5 Hz, 1H), 6.74 (dd, J = 7.6, 2.3 Hz, 2H), 6.66 (tt, J = 9.0, 2.3 Hz, 1H), 6.63 (br d, J = ca. 10.0 Hz, 1H), 5.55 (d, J = 7.8 Hz, 1H), 5.27 (br s, 1H), 5.14 (dd - like, J = 8.4, 3.0 Hz, 1H), 4.89 (dq, J = 9.5, 6.6 Hz, 1H), 4.84 (dd, J = 11.8, 1.9 Hz, 1H), 4.77 (q, J = 6.9 Hz, 1H), 4.52 (ddd - like, J = 10.0, 10.0, 1.9 Hz, 1H), 4.45 (br d, J = ca. 8.6 Hz, 1H), 4.33 (ddd - like, J = ca. 8.5, 7.8, 5.4 Hz, 1H), 3.77 (ddd, J = 11.3, 7.9, 5.0 Hz, 1H), 3.63 - 3.57 (m, 2H), 3.59 (dd, J = 11.8, 10.0, 1H), 3.51 (ddd, J = 11.6, 7.4, 7.4 Hz, 1H), 3.44 - 3.39 (m, 1H), 2.92 (dd, J = 13.4, 5.4 Hz, 1H), 2.87 (dd, J = 13.4, 8.5 Hz, 1H), 2.81 (s, 3H), 2.39 - 2.32 (m, 1H), 2.20 - 2.12 (m, 2H), 2.06 - 2.00 (m, 1H), 2.00 - 1.92 (m, 6H), 1.88 - 1.82 (m, 1H), 1.74 - 1.64 (m, 2H), 1.52 (d, J = 6.9 Hz, 3H), 1.39 - 1.30 (m, 2H), 1.34 (d, J = 6.6 Hz, 3H), 1.20 - 1.06 (m, 3H).

[0126] 13 C - NMR(CDCl 3 )(Chemical Shift): 172.3, 171.9, 171.8, 170.1, 170.0, 164.6, 162.8 (dd, J = 248, 12.4 Hz), 156.6, 140.3 (t, J = 8.6 Hz), 112.3 (dd, J = 21.2, 3.8 Hz), 102.2 (t, J = 24.8 Hz), 64.7, 59.3, 56.5, 56.3, 55.4, 51.0, 48.7, 47.9, 47.2, 46.4, 39.7, 33.9, 33.8, 30.94, 30.88, 30.7, 24.9, 23.1, 21.2, 17.4, 15.7.

[0127] HRMS (ESI+): [M+Na] + calcd for C 36 H 49 F 2 N 7 NaO 8 , 768.3508; found, 768.3503. These results confirmed that the compound was compound (19).

[0128] (Method for producing compound (20)) Compound (23) (133 mg, 0.19 mmol) was dissolved in a mixed solvent of tetrahydrofuran (1 mL) and N,N-dimethylformamide (1 mL), and then adamantyl isocyanate (33 mg, 0.19 mmol) and triethylamine (93 μL, 0.67 mmol) were added. The reaction solution was stirred at room temperature for 16 hours and then concentrated under reduced pressure. The residue was purified by column chromatography (EtOAc:EtOH=30:1) to obtain compound (20) as white crystals (12 mg, yield based on compound (23) 33%).

[0129] Regarding compound (20), 1 H-NMR, 13 The results of C-NMR and mass spectrometry (High-resolution electron spray ionization mass spectrometry, HR-ESI-MS) measurements are shown below.

[0130] 1 H-NMR (CDCl 3 ​)(Chemical Shift): 8.56 (d, J = 9.5 Hz, 1H), 7.02 (br d, J = ca. 10.0 Hz, 1H), 6.75 (dd, J = 7.5, 2.2 Hz, 2H), 6.65 (tt, J = 8.9, 2.2 Hz, 1H), 5.47 (d, J = 7.7 Hz, 1H), 5.36 (br s, 1H), 5.15 (dd-like, J = 8.3, 2.9 Hz, 1H), 4.89 (dq, J = 9.5, 6.6 Hz, 1H), 4.83 (dd, J = 11.7, 1.6 Hz, 1H), 4.77 (q, J = 6.9 Hz, 1H), 4.52 (ddd, J = 10.0, 9.5, 1.6 Hz, 1H), 4.46 (br d, J = ca. 8.3 Hz, 1H), 4.32 (ddd-like, J = ca. 8.5, 7.7, 5.3 Hz, 1H), 3.76 (ddd, J = 11.6, 8.0, 5.1 Hz), 3.64 (dd-like, J = ca. 11.6, 10.0 Hz, 1H), 3.65 - 3.61 (m, 1H), 3.52 (ddd, J = 11.6, 6.4, 6.4 Hz, 1H), 3.49 - 3.44 (m, 1H), 2.90 (dd, J = 13.2, 5.3 Hz, 1H), 2.86 (dd, J = 13.2, 8.5 Hz, 1H), 2.81 (s, 3H), 2.39 - 2.32 (m, 1H), 2.20 - 2.11 (m, 2H), 2.09 - 2.05 (m, 3H), 2.06 - 2.02 (m, 1H), 2.00 - 1.92 (m, 10H), 1.68 - 1.66 (m, 6H), 1.52 (d, J = 6.9 Hz, 3H), 1.32 (d, J = 6.6 Hz, 3H).

[0131] 13 C-NMR(CDCl 3 )(Chemical Shift): 172.5, 171.99, 171.97, 170.3, 170.1, 164.9, 162.9 (dd, J = 247, 12.4 Hz), 156.5, 140.5 (t, J = 9.1 Hz), 112.5 (dd, J = 21.1, 3.8 Hz), 102.2 (t, J = 24.9 Hz), 64.8, 59.4, 56.6, 56.2, 55.0, 51.0, 50.7, 47.9, 47.2, 46.5, 42.5, 39.6, 36.5, 30.9 (2C), 30.7, 29.5, 23.1, 21.2, 17.4, 15.6.

[0132] HRMS(ESI+): [M + Na]+ calcd for C 40 H 53 F 2 N 7 NaO 8 , 820.3821; found, 820.3811. These results confirmed that the compound was compound (20).

[0133] (Method for producing compound (21)) Compound (23) (81 mg, 0.11 mmol) was dissolved in a mixed solvent of tetrahydrofuran (1 mL) and N,N-dimethylformamide (1 mL), and then 4-(trifluoromethoxy)phenyl isocyanate (20 μL, 0.13 mmol) and triethylamine (56 μL, 0.40 mmol) were added. The reaction solution was stirred at room temperature for 16 hours and then concentrated under reduced pressure. The residue was purified by column chromatography (EtOAc:EtOH=15:1) to obtain compound (21) as white crystals (3.5 mg, yield based on compound (23) 4%).

[0134] Regarding compound (21), 1 H-NMR, 13 The results of C-NMR and mass spectrometry (High-resolution electron spray ionization mass spectrometry, HR-ESI-MS) measurements are shown below.

[0135] 1 H-NMR (CDCl 3 ​(Chemical Shift): 8.50 (d, J = 9.5 Hz, 1H), 8.08 (s, 1H), 7.47 (d, J = 9.1 Hz, 2H), 7.13 (d, J = 9.1 Hz, 2H), 7.00 (br d, J = ca. 10.0 Hz, 1H), 6.76 (dd, J = 7.5, 2.3 Hz, 2H), 6.67 (tt, J = 9.0, 2.3 Hz, 1H), 5.85 (d, J = 7.6 Hz, 1H), 5.16 (dd - like, J = 8.4, 3.1 Hz, 1H), 4.93 (dq, J = 9.5, 6.6 Hz, 1H), 4.86 (dd, J = 11.8, 1.8 Hz, 1H), 4.77 (q, J = 6.9 Hz, 1H), 4.55 (ddd - like, J = 10.0, 10.0, 1.8 Hz, 1H), 4.475 (ddd - like, J = ca. 8.9, 7.6, 4.7 Hz, 1H), 4.478 (d, J = 8.1 Hz, 1H), 3.78 (ddd, J = 11.5, 7.8, 5.0 Hz, 1H), 3.61 (ddd, J = 11.9, 8.6, 8.6 Hz, 1H), 3.57 (dd, J = 11.8, 10.0 Hz, 1H), 3.58 - 3.54 (m, 1H), 3.38 (ddd, J = 11.9, 9.6, 3.2 Hz, 1H), 2.99 (dd, J = 13.3, 4.7 Hz, 1H), 2.93 (dd, J = 13.3, 8.9 Hz, 1H), 2.82 (s, 3H), 2.41 - 2.34 (m, 1H), 2.19 - 2.13 (m, 2H), 2.06 - 1.96 (m, 3H), 1.96 - 1.89 (m, 2H), 1.54 (d, J = 6.9 Hz, 3H), 1.34 (d, J = 6.6 Hz, 3H).

[0136] 13 C - NMR (CDCl 3 ) (Chemical Shift): 172.2, 172.0, 171.8, 170.9, 170.1, 164.6, 163.0 (dd, J = 247, 12.4 Hz), 154.6, 143.8, 139.7 (t, J = 9.1 Hz), 138.4, 121.8, 120.5 (q, J = 256.1, 256.1, 256.1 Hz), 119.1, 112.6 (dd, J = 20.3, 3.8 Hz), 102.5 (t, J = 22.9 Hz), 65.0, 59.5, 56.7, 56.3, 55.2, 51.2, 48.0, 47.2, 46.6, 39.8, 31.0, 30.9, 30.6, 23.1, 21.2, 17.5, 15.6.

[0137] HRMS (ESI+): [M+Na] + calcd for C 37 H 42 F 5 N 7 NaO 8 , 846.2862; found, 846.2858. These results confirmed that the compound was compound (21).

[0138] (Method for producing compound (22)) Compound (23) (80 mg, 0.11 mmol) was dissolved in a mixed solvent of tetrahydrofuran (1 mL) and N,N-dimethylformamide (1 mL), and then 3-methoxyphenyl isocyanate (17 μL, 0.13 mmol) and triethylamine (55 μL, 0.39 mmol) were added. The reaction solution was stirred at room temperature for 16 hours and then concentrated under reduced pressure. The residue was purified by column chromatography (EtOAc:EtOH=15:1) to obtain compound (22) as white crystals (4.0 mg, yield 5% based on compound (23)).

[0139] Regarding compound (22), 1 H-NMR, 13 The results of C-NMR and mass spectrometry (High-resolution electron spray ionization mass spectrometry, HR-ESI-MS) measurements are shown below.

[0140] 1 H-NMR (CDCl 3 ​(Chemical Shift): 8.55 (d, J = 9.5 Hz, 1H), 8.19 - 8.15 (m, 1H), 7.97 (s, 1H), 6.97 - 6.83 (m, 1H), 6.86 - 6.83 (m, 1H), 6.77 (dd, J = 7.5, 2.3 Hz, 2H), 6.73 (br d, J = ca. 10.0 Hz, 1H), 6.67 (tt, J = 8.9, 2.3 Hz, 1H), 6.19 (d, J = 7.6 Hz, 1H), 5.15 (dd - like, J = 8.5, 3.0 Hz, 1H), 4.92 (dq, J = 9.5, 6.6 Hz, 1H), 4.85 (dd, J = 11.9, 2.0 Hz, 1H), 4.78 (q, J = 7.1 Hz, 1H), 4.56 (ddd - like, J = ca. 10.0, 9.5, 2.0 Hz, 1H), 4.48 (br d, J = 8.0 Hz, 1H), 4.43 (ddd, J = 8.9, 7.8, 5.0 Hz, 1H), 3.83 (s, 3H), 3.77 (ddd, J = 11.5, 7.8, 5.0 Hz, 1H), 3.70 (ddd, J = 12.4, 8.7, 8.7 Hz, 1H), 3.58 (dd, J = 11.9, 10.0 Hz, 1H), 3.54 (ddd, J = 11.7, 7.6, 7.6 Hz, 1H), 3.41 (ddd, J = 12.4, 9.8, 3.2 Hz, 1H), 3.02 (dd, J = 13.3, 5.0 Hz, 1H), 2.95 (dd, J = 13.3, 8.9 Hz, 1H), 2.84 (s, 3H), 2.40 - 2.33 (m, 1H), 2.22 - 2.12 (m, 2H), 2.03 - 1.94 (m, 3H), 1.94 - 1.83 (m, 2H), 1.53 (d, J = 7.1 Hz, 3H), 1.37 (d, J = 6.6 Hz, 3H).

[0141] 13 C - NMR (CDCl 3) (chemical shift): 172.5, 172.0, 171.6, 170.2, 170.0, 164.7, 163.0 (dd, J=247, 12. 4Hz), 154.7, 147.9, 140.2 (t, J = 9.1Hz), 129.2, 121.8, 121.2, 118.8, 112.5 ( d, J=20.1Hz), 110.3, 102.4 (t, J=24.8Hz), 64.7, 59.3, 56.6, 56.3, 55.8, 55. 6, 51.1, 48.0, 47.0, 46.5, 39.5, 30.92, 30.90, 30.6, 23.1, 21.3, 17.5, 15.6.

[0142] HRMS (ESI+): [M+Na] + calcd for C 37 H 45 F 2 N 7 NaO 9 , 792.3145; found, 792.3116. The results were as above, and it was confirmed that the compound was compound (22).

[0143] (Method for producing compound (24)) Compound (23) (106 mg, 0.15 mmol) was dissolved in a mixed solvent of tetrahydrofuran (1 mL) and N,N-dimethylformamide (1 mL), and then cyclohexyl isocyanate (22 μL, 0.18 mmol) and triethylamine (74 μL, 0.53 mmol) were added. The reaction solution was stirred at room temperature for 3 hours and then concentrated under reduced pressure. The residue was purified by column chromatography (EtOAc:EtOH=15:1) to obtain compound (24) as white crystals (12 mg, 11% yield based on compound (23)).

[0144] Regarding compound (24), 1 H-NMR, 13 The results of C-NMR and mass spectrometry (High-resolution electrospray ionization mass spectrometry, HR-ESI-MS) measurements are shown below.

[0145] 1 H-NMR (CDCl 3 ​)(Chemical Shift): 8.55 (d, J = 9.5 Hz, 1H), 7.32 (br d, J = ca. 10.0 Hz, 1H), 6.74 (dd, J = 7.6, 2.3 Hz, 2H), 6.64 (tt, J = 9.0, 2.3 Hz, 1H), 5.49 (d, J = 7.8 Hz, 1H), 5.45 (br d, J = ca. 7.0 Hz, 1H), 5.16 (dd-like, J = 8.5, 3.2 Hz, 1H), 4.87 (dq, J = 9.5, 6.6 Hz 1H), 4.84 (dd, J = 11.9, 1.8 Hz, 1H), 4.78 (q, J = 6.9 Hz, 1H), 4.53 (ddd-like, J = ca. 10.0, 10.0, 1.8 Hz, 1H), 4.45 (d, J = 8.5 Hz, 1H), 4.10 (ddd-like, J = ca. 8.5, 7.7, 5.4 Hz, 1H), 3.76 (ddd, J = 11.5, 7.8, 5.0 Hz, 1H), 3.63 - 3.54 (m, 2H), 3.59 (dd-like, J = ca. 11.9, 10.0, 1H), 3.41 (ddd, J = 11.5, 9.6, 3.0 Hz, 1H), 2.92 (dd, J = 13.2, 8.5 Hz, 1H), 2.90 (dd, J = 13.2, 5.4 Hz, 1H), 2.79 (s, 3H), 2.39 - 2.32 (m, 1H), 2.20 - 2.12 (m, 2H), 2.05 - 1.88 (m, 2H), 1.72 - 1.62 (m, 2H), 1.61 - 1.54 (m, 2H), 1.47 - 1.40 (m, 1H), 1.51 (d, J = 6.9 Hz, 3H), 1.38 - 1.31 (m, 1H), 1.29 (d, J = 6.6 Hz, 3H).

[0146] 13 C-NMR(CDCl 3 )(Chemical Shift): 172.5, 172.02, 171.98, 170.3, 170.1, 164.8, 162.8 (dd, J = 249, 12.5 Hz), 157.2, 140.5 (t, J = 8.7 Hz), 112.6 (dd, J = 20.2, 2.9 Hz), 102.8 (t, J = 25.1 Hz), 65.0, 59.3, 56.6, 56.2, 54.7, 51.7, 51.1, 47.9, 47.1, 46.5, 39.5, 33.55, 33.46, 30.9, 30.8, 30.7, 23.62, 23.59, 23.1, 21.1, 17.4, 15.6.

[0147] HRMS (ESI+): [M+Na] + calcd for C 36 H 49 F 2 N 7 NaO 8 , 768.3508; found, 768.3503. These results confirmed that the compound was compound (24).

[0148] Using the above compounds (1) to (22), compound (24), Compound 1, and ADEP1, the minimum inhibitory concentrations were determined for the above three types of bacteria according to standard methods. The results are shown in Table 1. ADEP1 has a structure represented by formula (4). The general formulas of compound 1 (formula (2)) and the compounds of the present invention (formulas (1) and (2)), and the functional group moieties (formula (3)) of compounds (1) to (22) and compound (24) are also shown below.

[0149]

[0150]

[0151]

[0152]

[0153] Units are (μg / mL)

[0154] Referring to Table 1, against B. subtilis ATCC6051, compounds (3), (4), (5), (6), (7), and (9) exhibited antibacterial activity 32-fold, 128-fold, 4-fold, 4-fold, 4-fold, and 16-fold higher than that of ADEP1. Furthermore, compounds (3), (4), and (9) exhibited antibacterial activity 6-fold, 26-fold, and 3-fold higher than that of compound 1. Meanwhile, compounds (5), (6), and (7) exhibited antibacterial activity at a level similar to that of compound 1.

[0155] Compound (3) exhibited antibacterial activity against S. epidermidis ATCC 12228 that was 32 times higher than that of ADEP1. Furthermore, compound (3) exhibited antibacterial activity that was twice as high as that of compound 1.

[0156] Against B. cereus ATCC11778, compounds (3), (5), (14), and (16) exhibited antibacterial activity twice as high as that of ADEP1.

[0157] Furthermore, the difference between compound (6) and compound (22) is the position of the methoxy group bonded to the benzene ring, which is meta and para, but the antibacterial activity is almost the same. Therefore, it is considered that the position of the terminal functional group bonded to the phenyl group has almost no effect on the antibacterial activity.

[0158] The cyclic peptide compound of the present invention has antibacterial effects against various bacteria and can be provided as an antibacterial agent. Furthermore, by utilizing the cyclic peptide compound of the present invention in cell biology, molecular biology, and biochemistry research, it is useful not only as a research tool for elucidating the protein degradation system in microorganisms but also as a drug discovery seed with a new mechanism of action.

Claims

1. A cyclic peptide compound having the structure of formula (1). Here, R1 is any of a phenyl group, a naphthyl group, a cyclohexyl group, an adamantane group, a C3 to C18 linear alkyl group, and a phenyl group in which any hydrogen has been substituted (the substituted functional group is any of a C3 to C18 linear alkyl group, a C1 to C3 alkoxyl group, a halogen group, a C1 to C3 perfluoroalkyl group, a nitro group, a trifluoromethoxy group, and a cyclopentyl group.

2. The cyclic peptide compound according to claim 1, wherein the linear alkyl group has 3, 4, 6, 7, 12 or 18 carbon atoms, and among the substituted functional groups, the alkyl group has 1, 2 or 4 carbon atoms, the alkoxyl group has 1 or 2 carbon atoms, the halogen group is fluorine or chlorine, and the perfluoroalkyl group has 1 carbon atom.

3. An antibacterial agent comprising any one of the cyclic peptide compounds described in claim 1 or 2.

Citation Information

Patent Citations

  • antibacterial macro ring

    JP2005510468A

  • Substituted urea depsipeptide analogs as activators of the CLPP endopeptidase

    WO2015031871A1

  • Substituted urea depsipeptide analogs as activators of the CLPP endopeptidase

    WO2016141351A1